EACR 2021 Virtual Congress: A Participant’s View
At the beginning of June 2021, the EACR hosted its second Virtual Congress with 4 days of high quality speaker talks, an online Poster Discussion session, a virtual exhibition and a networking...
At the beginning of June 2021, the EACR hosted its second Virtual Congress with 4 days of high quality speaker talks, an online Poster Discussion session, a virtual exhibition and a networking...
In June 2020 we announced the success of the EuCanImage Consortium, whose €10-million grant proposal was selected for funding by the European Commission and launched a few months later in October 2020....
The highly anticipated EACR Congress for 2021 was hosted virtually for the second year in a row. The four-day festival, from 09-12 June 2021, saw high quality scientific presentations and discussions delivered...
The struggle is real It has been over a year that we have been struggling with COVID-19 pandemic. Little did we know it would be dragged this long from when it was...
May saw us host Bioinformatics in Cancer, which took place virtually from 18-19 May. The meeting covered a wide range of topics in the field of bioinformatics, including single cell data analysis,...
Corinna Keup writes for the EACR in the latest Industry Sponsored article about her research studies on liquid biopsies. Title: Postdoctoral Researcher Institution: Department of Gynecology and Obstetrics, University Hospital of Essen,...
This article first featured here on the Neuroblastoma blog, which features regular articles about Olga Piskareva's lab group and their activities. By visiting Catherine's article, you can also read more about the...
Professor Andrea Ablasser of the Swiss Federal Institute of Technology in Lausanne (EFPL), Switzerland, is the first winner of the Pezcoller Foundation-EACR Translational Cancer Researcher Award. The award celebrates academic excellence and...
The ReIMAGINE Consortium The ReIMAGINE Consortium aims to, for the first time, combine biomarkers (blood, urine and tissue) with state-of-the-art imaging to predict which prostate cancers are likely to progress over time...